BillionToOne is ranked at the top 5% of Y Combinator companies with close to $400M in funding. In June 2024, we closed a $130M Series D resulting in a company valuation of over $1 billion. This funding has come from prestigious global institutional …

BillionToOne (YC S17) is ranked at the top 5% of Y Combinator companies with $300M+ in funding from top VC firms. We have developed a DNA molecular counter that increases cfDNA diagnostic resolution by over 1,000x. Our first product, Unity, is the f…

BillionToOne (YC S17) is ranked at the top 5% of Y Combinator companies with $300M+ in funding from top VC firms. We have developed a DNA molecular counter that increases cfDNA diagnostic resolution by over 1,000x. Our first product, UNITY, is the f…

BillionToOne (YC S17) is ranked at the top 5% of Y Combinator companies with $300M+ in funding from top VC firms. We have developed a DNA molecular counter that increases cfDNA diagnostic resolution by over 1,000x. Our first product, UNITY, is the f…